EA200500741A1 - CONSORTIUM bifidobacteria Bifidobacterium bifidum 791-MB, Bifidobacterium longum in 379M- MB, BIFIDOBACTERIUM ADOLESCENTIS D 7513-MB, BIFIDOBACTERIUM INFANTIS 73-15-MB, BIFIDOBACTERIUM BREVE 79-119-MB, used to prepare fermented milk, unfermented PRODUCTS, biologically active ADDITIVES, BIFIDIFICATION-CONTAINING PREPARATIONS, COSMETIC AND HYGIENIC MEANS - Google Patents
CONSORTIUM bifidobacteria Bifidobacterium bifidum 791-MB, Bifidobacterium longum in 379M- MB, BIFIDOBACTERIUM ADOLESCENTIS D 7513-MB, BIFIDOBACTERIUM INFANTIS 73-15-MB, BIFIDOBACTERIUM BREVE 79-119-MB, used to prepare fermented milk, unfermented PRODUCTS, biologically active ADDITIVES, BIFIDIFICATION-CONTAINING PREPARATIONS, COSMETIC AND HYGIENIC MEANSInfo
- Publication number
- EA200500741A1 EA200500741A1 EA200500741A EA200500741A EA200500741A1 EA 200500741 A1 EA200500741 A1 EA 200500741A1 EA 200500741 A EA200500741 A EA 200500741A EA 200500741 A EA200500741 A EA 200500741A EA 200500741 A1 EA200500741 A1 EA 200500741A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- bifidobacterium
- consortium
- bifidobacteria
- infantis
- breve
- Prior art date
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
Abstract
Изобретение относится к биотехнологии, касается консорциума штаммов бифидобактерий, который может быть использован для приготовления различных форм бактерийных препаратов, препаратов-пробиотиков на его основе, функциональных продуктов питания, биологически активных добавок, неферментированных продуктов, кисло-молочных продуктов косметических и гигиенических средств. Для получения консорциума использованы следующие штаммы бифидобактерий: Bifidobacterium bifidum 791-МБ, Bifidobacterium longum В 379М-МБ, Bifidobacterium adolescentis Г 7513-МБ, Bifidobacterium infantis 73-15-МБ, Bifidobacterium breve 79-119-МБ, характерной особенностью которых является высокая антибиотическая и супероксиддисмутазная активность с выраженной антиоксидантной активностью. Супероксиддисмутазная активность консорциума не ниже 24,9 ед/мг белка микробной массы. Проявляемая специфическая активность, способность к утилизации широкого спектра аминокислот, высокая антибиотикоустойчивость позволили повысить устойчивость консорциума к повреждающим факторам агрессивных сред гастроинтестинального тракта при прохождении бифидобактерий в желудочно-кишечном тракте и повышения таким образом его колонизирующей активности.The invention relates to biotechnology, concerns a consortium of strains of bifidobacteria, which can be used to prepare various forms of bacterial preparations, probiotic preparations based on it, functional foods, dietary supplements, non-fermented products, sour-milk products of cosmetic and hygiene products. The following strains of bifidobacteria were used to obtain a consortium: Bifidobacterium bifidum 791-MB, -s, Bifidobacterium longum B 379M-MB, Bifidobacterium adolescentis G 7513-MB, Bifidobacterium infantis 73-15-MB, Bifidobacterium breve 79-1 MB, Bifidobacterium infantis 73-15-MB, Bifidobacterium breve 79-1 MB, Bifidobacterium infantis 73-15-MB, Bifidobacterium breve 79-1 MB, Bifidobacterium infantis 73-15-MB and superoxide dismutase activity with pronounced antioxidant activity. The superoxide dismutase activity of the consortium is not lower than 24.9 units / mg of microbial protein. Manifested specific activity, ability to utilize a wide range of amino acids, high antibiotic resistance allowed the consortium to be resistant to the damaging factors of aggressive gastrointestinal tract during the passage of bifidobacteria in the gastrointestinal tract and thus increasing its colonizing activity.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2004130595/13A RU2261909C1 (en) | 2004-10-20 | 2004-10-20 | BIFIDUS-BACTERIUM CONSORTIUM OF Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium adolescentis, Bifidobacterium infantis, Bifidobacterium breve USEFUL IN PREPARATION OF FERMENTED-MILK AND NONFERMENTED PRODUCTS, BIOACTIVE SUPPLEMENT, BIFIDOBACTERIA- CONTAINING PRODUCT, COSMETIC AND TOILETRY AGENTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA006509B1 EA006509B1 (en) | 2005-12-29 |
| EA200500741A1 true EA200500741A1 (en) | 2005-12-29 |
Family
ID=35507805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200500741A EA200500741A1 (en) | 2004-10-20 | 2005-05-30 | CONSORTIUM bifidobacteria Bifidobacterium bifidum 791-MB, Bifidobacterium longum in 379M- MB, BIFIDOBACTERIUM ADOLESCENTIS D 7513-MB, BIFIDOBACTERIUM INFANTIS 73-15-MB, BIFIDOBACTERIUM BREVE 79-119-MB, used to prepare fermented milk, unfermented PRODUCTS, biologically active ADDITIVES, BIFIDIFICATION-CONTAINING PREPARATIONS, COSMETIC AND HYGIENIC MEANS |
Country Status (3)
| Country | Link |
|---|---|
| EA (1) | EA200500741A1 (en) |
| RU (1) | RU2261909C1 (en) |
| UA (1) | UA74316C2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT5578B (en) | 2007-08-20 | 2009-06-25 | Uab "Bifidum Medical" | The composition of nutritional or pharmaceutical biopreparation |
| RU2451726C2 (en) * | 2010-05-14 | 2012-05-27 | Татьяна Александровна Левченко | Bifidobacterium adolescentis STRAIN USED TO OBTAIN BIFIDO-CONTAINING PRODUCT |
| RU2451725C2 (en) * | 2010-05-14 | 2012-05-27 | Татьяна Александровна Левченко | Bifidobacterium adolescentis STRAIN USED TO OBTAIN PRODUCT |
| RU2451728C2 (en) * | 2010-05-28 | 2012-05-27 | Татьяна Александровна Левченко | Bifidobacterium longum STRAIN USED TO OBTAIN BIFIDO-CONTAINING PRODUCT |
| LT6202B (en) | 2013-08-02 | 2015-07-27 | Null, Null | Composition for nutritional or pharmaceutical biopreparation |
| RU2597827C1 (en) * | 2015-08-28 | 2016-09-20 | Олег Иванович Квасенков | Bread kvass production method |
| CN112167346B (en) * | 2019-07-05 | 2023-07-25 | 内蒙古伊利实业集团股份有限公司 | Food composition and pharmaceutical composition containing lactobacillus strain for antioxidation |
| CN112167345B (en) * | 2019-07-05 | 2023-07-25 | 内蒙古伊利实业集团股份有限公司 | Food composition and pharmaceutical composition containing antioxidant lactobacillus fermentation product |
| CN112410241A (en) * | 2019-08-22 | 2021-02-26 | 丰华生物科技股份有限公司 | Antioxidant composition containing lactobacillus strain or its fermented product and its application |
| RU2752891C1 (en) * | 2021-01-12 | 2021-08-11 | Общество с ограниченной ответственностью "Научно-производственное объединение Бифилайф" | Consortium of bifidobacterium used to prepare bifidobacterium products and strains that are part of consortium |
| TWI797881B (en) * | 2021-12-08 | 2023-04-01 | 豐華生物科技股份有限公司 | Anti-aging composition and use thereof for preventing aging |
-
2004
- 2004-10-20 RU RU2004130595/13A patent/RU2261909C1/en active
-
2005
- 2005-05-30 EA EA200500741A patent/EA200500741A1/en not_active IP Right Cessation
- 2005-07-15 UA UAA200507066A patent/UA74316C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2261909C1 (en) | 2005-10-10 |
| UA74316C2 (en) | 2005-11-15 |
| EA006509B1 (en) | 2005-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200500741A1 (en) | CONSORTIUM bifidobacteria Bifidobacterium bifidum 791-MB, Bifidobacterium longum in 379M- MB, BIFIDOBACTERIUM ADOLESCENTIS D 7513-MB, BIFIDOBACTERIUM INFANTIS 73-15-MB, BIFIDOBACTERIUM BREVE 79-119-MB, used to prepare fermented milk, unfermented PRODUCTS, biologically active ADDITIVES, BIFIDIFICATION-CONTAINING PREPARATIONS, COSMETIC AND HYGIENIC MEANS | |
| WO2022041656A1 (en) | Lactobacillus paracasei 207-27 and application thereof | |
| Sanders | Considerations for use of probiotic bacteria to modulate human health | |
| Soccol et al. | The potential of probiotics: a review. | |
| ES2311729T3 (en) | PROBIOTIC CEPAS, A PROCEDURE FOR THE SELECTION OF THEM, COMPOSITIONS OF THE SAME AND ITS USE. | |
| ES2168785T5 (en) | ABSORPTION OF MINERALS BY INTESTINAL CELLS. | |
| WO2022041658A1 (en) | Bifidobacterium breve 207-1 and use thereof | |
| ES2333479T3 (en) | FOOD PRODUCT THAT INCLUDES BACTERIA AND SORBITAN FAT ACID. | |
| Gupta et al. | 'Lactic Acid Bacteria: Probiotic Characteristic, Selection Criteria, and its Role in Human Health (A Review)' | |
| ES2545209T3 (en) | Method of obtaining a new strain of Bifidobacterium bifidum with activity against Helicobacter pylori infection | |
| EA200701992A1 (en) | MIXTURE AT LEAST OF 6 MILK-ACID BACTERIA AND / OR BIFIDOBACTERIUM TYPES IN FERMENT PRODUCTION | |
| ES2285460T3 (en) | PROBIOTIC COMPOSITION THAT INCLUDES AT LEAST TWO BACTERIAL LACTICO ACID BODIES COLONIZING CAPACES COLONIZING GASTROINTESTINAL TRACTS TOGETHER WITH POSSESSION OF PROPERTIES OF INTESTINAL SURVIVAL, INTESTINAL UNION, PROTECTION AGAINST INFECTION AND FIBENTATION OF FIBENTATION. | |
| TW202108757A (en) | Composition with anti-oxidation strains or postbiotics of lactic acid bacterium and uses thereof | |
| ES2553177T3 (en) | Strains of Lactobacillus plantarum as probiotics with specific immunomodulatory effect | |
| AU2017327485B2 (en) | Bacteria | |
| JPWO2018181069A1 (en) | Opioid peptide degradation composition | |
| CN109715181B (en) | Bacteria | |
| Vemuri et al. | Probiotics: a novel approach in improving the values of human life | |
| Ukeyima et al. | Current applications of probiotic foods in Africa | |
| El Sayed et al. | Encapsulation of probiotics using mixed sodium alginate and rice flour to enhance their survivability in simulated gastric conditions and in UF-Kariesh cheese | |
| Pimentel | Probióticos e benefícios à saúde | |
| JP2019208486A (en) | Composition containing lactic acid bacterium, and composition for immunostimulation | |
| Horie et al. | Anaerobic induction of adherence to laminin in Lactobacillus gasseri strains by contact with solid surface | |
| Ramchandran | Physico-chemical and therapeutic properties of low-fat yogurt as influenced by fat replacers, exopolysaccharides and probiotics | |
| JP2024046233A (en) | Composition for improving intestinal barrier |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): MD |
|
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG TM |
|
| PC4A | Registration of transfer of a eurasian patent by assignment |